Hepatitis after blood transfusions in hospitalized patients: Post- transfusion hepatitis or hepatitis of other aetiology?;Hepatitis nach stationarer bluttransfusion: Posttransfusionshepatitis oder infektion anderer atiologie?

Deutsche Medizinische Wochenschrift

Volumn 125, Issue 8, 2000, Pages 211-215

  Mahl, Marc Alexander ^a   Sugg, U ^a  

^a Katharinenhospital Stuttgart   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CLINICAL ARTICLE; HEPATITIS B; HEPATITIS C; HEPATITIS NON A NON B; HOSPITAL PATIENT; HUMAN; INFECTION RISK; RECIPIENT; SEROCONVERSION; VIRUS DIAGNOSIS; BLOOD COMPONENT THERAPY; DISEASE TRANSMISSION; FOLLOW UP; RETROSPECTIVE STUDY; TIME;

BLOOD COMPONENT TRANSFUSION; BLOOD TRANSFUSION; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS C; HUMANS; INPATIENTS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0034712316     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024051     Document Type: Article

References (31)

1. 1. Allander, T., A. Graber: Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 345 (1995), 603-607.
2. 2. Alter, M. J., S. C. Hadler, F. N. Judson, A. Mares, W. J. Alexander, P. Y. Hu, J. K. Miller, L. A. Moyer, H. A. Fields, D. W. Bradley, H. S. Margolis: Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C infection. J. A. M. A. 264 (1990), 2231-2235.
3. 3. Alter, M.J., H. S. Margolis, K. Krawczynski, F. N. Judson, A. Mares, W. J. Alexander, P. Y. Hu, J. K. Miller, M. A. Gerber, R. E. Sampliner, E. L. Meeks, M. J. Beach: The natural history of community-acquired hepatitis C in the United States. N. Engl. J. Med. 327 (1992), 1899-1906.
4. 4. Arbeitskreis Blut: Empfehlungen der Ad-hoc-Kommission des Arbeitskreises Blut zum Rückverfolgungsverfahren (look back) für Einzelspender und Kleinpool-Blutpräparate. Bundesgesundheitsblatt 12 (1994), 513-514.
5. 5. Berk, J.E.: Hepatitis following transfusion. Gastroenterology 8 (1947), 296-310.
6. 6. Conry-Cantilena, C., M. van Raden, J. Gibble, J. Melpolder, A. O. Shakil, L. Viladomiu, L. Cheung, A. DiBisceglie, J. Hoofnagle, J. W. Shih, R. Kaslow, P. Ness, H. J. Alter: Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N. Engl. J. Med. 334 (1996), 1691-1696.
7. 7. Dodd, R.Y.: Adverse consequences of blood transfusion: quantitative risk estimates. In: Nance, ST. : Blood supply: risk, perceptions and prospects for the future. Bethesda, Md: AABB, 1994: 1-24.
8. 8. Editorial: Hepatitis following the administration of human serum. Ann. Intern. Med. 19 (1943), 368-371.
9. 9. Esteban, J.I., J. Gómez, M. Martell, B. Cabot, J. Quer, J. Camps, A. González, T. Otero, A. Moya, R. Esteban, J. Guardia: Transmission of hepatitis C virus by a cardiac surgeon. N. Engl. J. Med. 334 (1996), 555-560.
10. 10. Farci, P., W. T. London, D. C. Wong, G. J. Dawson, D. S. Vallari, R. Engle, R. H. Purcell: The natural history of infection with hepatitis C virus (HCV) in chimpanzees: Comparison of serologic responses measured with first and second generation assays and relationship to HCV viremia. J. Infect. Dis. 165 (1992), 1006-1013.
11. 11. Glück, D., B. Kubanek, C. Maurer, N. Petersen: Seroconversion of HIV, HCV and HBV in blood donors in 1996 - risk of virus transmission by blood products in germany. Infusionsther. Transfusionsmed. 25 (1998), 82-84.
12. 12. Harpaz, R., L. von Seidlein, F. M. Averhoff, M. P. Tormey, S. D. Sinha, K. Kotsopoulou, S. B. Lambert, B. H. Robertson, J. D. Cherry, C. N. Shapiro: Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N. Engl. J. Med. 334 (1996), 549-554.
13. 13. Havens W.P. Jr.: The etiology of infectious hepatitis. J. A. M. A. 134 (1947), 653-655.
14. 14. Hoofnagle, J.H., L. B. Seeff, Z. B. Bales, H. J. Zimmerman: Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N. Engl. J. Med. 298 (1978), 1379-1383.
15. 15. Japanese red cross non-A, non-B hepatitis research group. : Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Lancet 338 (1991), 1040-1041.
16. 16. Koerner, K., M. Da Silva Cardoso, T. Dengler, M. Kerowgan, B. Kubanek: Look back on hepatitis C-virus infections of HCV-RIBA-2-positive blood donors and their respective recipients. Vox. Sang. 69 (1995), 78-79.
17. 17. Kozarek, R. A.: Transmission of hepatitis C virus during colonos-copy. N. Engl. J. Med. 337 (1997), 1848-1849.
18. 18. McLindon, J.P., W. K. Paver, C. Babbs, A. D. Yates, R. F. T. McMahon, E. M. Love, J. Craske, J. Christopher, T. W. Warnes: Hepatitis C related chronic liver disease among asymptomatic blood donors in the north west of England. J. Infect. 30 (1995), 253-259.
19. 19. Molijn, M. H. J., J. M. van der Linden, L. K. Ko, J. Gorgels, W. Hop, D. J. van Rhenen: Risk factors and anti-HBc reactivity among first time blood donors. Vox. Sang. 72 (1997), 207-210.
20. 20. Napoli, N., G. Fiore, F. Vella, G. Fera, O. Schiraldi: Prevalence of antibodies to hepatitis C virus among family members of patients with chronic hepatitis C. Eur. J. Epidemiol. 9 (1993), 629-632.
21. 21. NIH Consensus development panel on infectious disease testing for blood transfusions: Infectious disease testing for blood transfusions. J. A. M. A. 274 (1995), 1374-1379.
22. 22. Nübling, C.M., J. Löwer: The role of nucleic acid amplification techniques (NATs) in viral safety testing of blood and blood products. Biotest Bulletin 5 (1997), 377-381.
23. 23. Propert, S.A.: Hepatitis after prophylactic serum. Br. Med. J. 2 (1938), 677-678.
24. 24. Reesink, H.W., C. L. van der Poel: Blood transfusion and hepatitis: still a threat? Blut 58 (1989), 1-6.
25. 25. Schreiber, G.B. , M. P. Busch, S. H. Kleinman, J. J. Korelitz for the retrovirus epidemiology donor study: The risk of transfusion-transmitted viral infections. N. Engl. J. Med. 334 (1996), 1685-1690.
26. 26. Shev, S., S. Hermodsson, A. Lindholm, E. Malm, A. Widell, G. Norkrans: Risk factor exposure among Hepatitis C virus RNA positive swedish blood donors - the role of parenteral and sexual transmission. Scand. J. Infect. Dis. 27 (1995), 99-104.
27. 27. Staritz, M.: Transmission of hepatitis C in gastrointestinal endos-copy - media sensationalism or a clinically relevant problem ? Z. Gastroenterol. 36 (1998), 261-263.
28. 28. Sugg, U., S. Ehrhardt, T. Morgenroth, B. Flehmig: Is the use of the term "post-transfusion hepatitis type B" in its conventional sense still justifiable ? Vox. Sang. 44 (1983), 305-311.
29. 29. Sugg, U., S. Erhardt, W. Schneider: Chronic "low level" hepatitis B virus carrier with probable infectivity. Lancet i (1982), 446-447.
30. 30. Vrielink, H., H. W. Reesink, H. L. Zaaijer, E. Scholten, L. C. M. Kremer, H. T. M. Cuypers, P. N. Lelie, M. H. J. van Oers, C. L. van der Poel: Look-back of anti-HCV ELISA-positive, HCV-RNA PCR-negative donors and recipients of their blood products. Vox. Sang 72 (1997), 67-70.
31. 31. Wissenschaftlicher Beirat der Bundesärztekammer: Richtlinien zur Blutgruppenbestimmung und Bluttransfusion (Hämotherapie) Deutscher Ärzte-Verlag: Köln, 1996.